statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Partial results from its first major trial which Britain used to authorize the vaccine were clouded by a manufacturing mistake that researchers didn't immediately acknowledge. Read More...

AstraZeneca pulls its COVID-19 vaccine from European market after history of stumbles

Cambridge, U.K.-based pharma giant AstraZeneca said on Wednesday that it is no longer producing or supplying its COVID-19 vaccine, known as Vaxzeveria, due to shrinking demand. The news comes as...

AstraZenca is pulling its COVID vaccine

Pharmaceutical giant AstraZeneca on Wednesday said it planned to withdraw its Covid-19 vaccine as demand for it has declined...

AstraZeneca to withdraw Covid vaccine worldwide, citing a drop in demand

It is worth noting that AstraZeneca has previously conceded in court documents that Vaxzevria can induce side effects such as blood clots and low blood platelet counts.
read more...

AstraZeneca Pulls Plug On Vaxzevria COVID-19 Vaccine Amid Surplus of Updated Vaccines

AstraZeneca Pulls Covid Vaccine After Admitting Rare Side Effect

 In yet another damning development for the 'safe and effective' crowd, AstraZeneca has announced the worldwide withdrawal...

AstraZeneca Pulls Covid Vaccine After Admitting Rare Side Effect

Amgen, Viking Therapeutics, Altimmune, AstraZeneca, Boehringer Ingelheim and Zealand Pharma are making encouraging progress on their own treatments...

Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance

Systematic Review Reveals Many COVID-19 Vaccine Recipients Experienced New-Onset Psychosis

 Authored by Naveen Athrappully via The Epoch Times (emphasis ours),

Individuals who took...

Systematic Review Reveals Many COVID-19 Vaccine Recipients Experienced New-Onset Psychosis

Top Five Cancer Types Dominate New US Cases as Biotech Sector Eyes $314B Market by 2032 Top Five Cancer Types Dominate New US Cases as Biotech Sector Eyes $314B Market by 2032 PR Newswire VANCOUVER...

Top Five Cancer Types Dominate New US Cases as Biotech Sector Eyes $314B Market by 2032

Positive high-level results from an interim analysis of the ECHO Phase III trial showed AstraZenecas CALQUENCE (acalabrutinib) in combination with standard-of-care chemoimmunotherapy, bendamustine...

CALQUENCE combination regimen demonstrated statistically significant and clinically meaningful improvement in progression-free survival in 1st-line mantle cell lymphoma in ECHO Phase III trial

Study Finds Elevated Risk Of Eye Inflammatory Disorder Following COVID-19 Vaccination

 Authored by Megan Redshaw, J.D. via The Epoch Times (emphasis ours),

People with a history of...

Study Finds Elevated Risk Of Eye Inflammatory Disorder Following COVID-19 Vaccination

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

Watchers	18,348
52-Wk Low	$60.47
52-Wk High	$77.16

Volume	1.81M
52-Wk High	$77.16
52-Wk Low	$60.47

AZN AstraZeneca PLC

About

Feed

News

Sentiment

Fundamentals

Sentiment

Message Volume

Community